MedTrace Logo

GERD After Sleeve Gastrectomy

NCT05178446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14362

Last updated 2022-01-05

No results posted yet for this study

Summary

The main adverse effect is gastroesophageal reflux disease (GERD), with concern on the development of Barrett's esophagus and esophageal adenocarcinoma in the long term. However, the relationship between SG and GERD is complex. The aim of this study is to systematically evaluate all published data existing in the literature to evaluate the effect of sleeve gastrectomy on GERD, esophagitis, BE in order to clarify the long-term clinical sequelae of this procedure.

This systematic review was conducted in accordance with the guidelines for Preferred Reporting Items for Systematic Review and Meta-analyzes (PRISMA).

Published studies that contained outcome data for primary sleeve gastrectomy associated with the primary and secondary outcomes listed below were included.

Conditions

  • Morbid Obesity
  • GERD

Sponsors & Collaborators

  • University of Foggia

    lead OTHER

Principal Investigators

  • Nicola Tartaglia · University of Foggia

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-03-01
Completion
2021-12-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05178446 on ClinicalTrials.gov